Efficacy of the NXSignal Device for the Treatment of Anterior Cruciate Ligament Injuries
Recruiting
N/A
Interventional Study
Anterior Cruciate Ligament Injuries
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 16 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 40 (estimated)
- Sponsor
- University of Las Palmas de Gran Canaria · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Injury to the anterior cruciate ligament (ACL) is very common among sports professionals and the general population \[. Unlike other joint injuries, it is reversible, but it can damage adjacent tissues, particularly the meniscus, and catalyze knee osteoarthritis.
ACL injury produces instability, joint mechanical alteration, which can lead to degenerative joint diseases. The goal of treating the i…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Over 16 years old
* In normal conditions and mentally competent to participate in the study.
* Not having previous knee surgeries.
* In condition to complete the study questionnaires.
Exclusion Criteria:
* Present some of the contraindications for a treatment with NESA XSIGN…
Contacts